Anticoagulação


Position Statement on the Use of Antiplatelet Agents and Anticoagulants in Patients Infected with the New Coronavirus (COVID-19) - 2020

Soeiro AM, Leal TCAT, Pereira MP, Lima EG, Figueiredo ACBDS, Petriz JLF, Precoma DB, Serrano CV Jr.

Abstract:

Link para artigo

[Learning with COVID-19: what about anticoagulation?]

Álvarez-Rodríguez E, González González R, Torres-Gárate R, López-Riquelme P, González Martil I, Abad Cuñado V.

Abstract:

Link para artigo

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients

Paolisso P, Bergamaschi L, D'Angelo EC, Donati F, Giannella M, Tedeschi S, Pascale R, Bartoletti M, Tesini G, Biffi M, Cosmi B, Pizzi C, Viale P, Galié N.

Abstract:

Link para artigo

Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?

Yeoh SA, Ehrenstein MR.

Abstract:

Link para artigo

COVID-19 and systemic lupus erythematosus: a case series

Gartshteyn Y, Askanase AD, Schmidt NM, Bernstein EJ, Khalili L, Drolet R, Broderick RJ, Geraldino-Pardilla L, Kapoor T.

Abstract:

Link para artigo

Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic

Marzo-Ortega H, Tan AL, Bissell LA, Morgan AW, Vandevelde C, Vital EM, Dass S.

Abstract:

Link para artigo

A 31-Year-Old Man with COVID-19-Associated Empyema and Lupus Anticoagulant

Yarlagadda K, Mi K, Sendil S, Koons CL, Komanduri S, Cinicola JT.

Abstract:

Link para artigo

Thrombolysis restores perfusion in COVID 19 hypoxia

Arachchillage DJ, Stacey A, Akor F, Scotz M, Laffan M.

Abstract:

Link para artigo

COVID-19 Pandemic: Are Patients with Inflammatory Bowel Disease Really at Risk?

Hassan SA, Ezeh J.

Abstract:

Link para artigo

Heparin-Induced Thrombocytopenia in COVID-19

Lingamaneni P, Gonakoti S, Moturi K, Vohra I, Zia M.

Abstract:

Link para artigo

[Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts' Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhyth

Shlyakhto YV, Arutyunov GP, Belenkov YN, Tarlovskaya EI, Konradi AO, Panchenko EP, Yavelov IS, Tereshchenko SN, Ardashev AV, Arutyunov AG, Grigorieva NY, Dzhunusbekova GA, Drapkina OM, Koziolova NA, Komarov AL, Kropacheva ES, Malchikova SV, Mitkovskaya NP, Orlova YA, Petrova MM, Rebrov AP, Sisakian H, Skibitsky VV, Sugraliyev AB, Fomin IV, Chesnikova AI, Shaposhnik II, Zhelyakov EG, Kanorskii SG, Kolotsey LV, Snezhitskiy VA.

Abstract:

Link para artigo

The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience

Pesavento R, Ceccato D, Pasquetto G, Monticelli J, Leone L, Frigo A, Gorgi D, Postal A, Marchese GM, Cipriani A, Saller A, Sarais C, Criveller P, Gemelli M, Capone F, Fioretto P, Pagano C, Rossato M, Avogaro A, Simioni P, Prandoni P, Vettor R.

Abstract:

Link para artigo

Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS

Turi S, Nardelli P, Landoni G.

Abstract:

Link para artigo

Antiviral anticoagulation

Pryzdial ELG, Sutherland MR, Lin BH, Horwitz M.

Abstract:

Link para artigo

Anticoagulation, immortality, and observations of COVID-19

Maley JH, Petri CR, Brenner LN, Chivukula RR, Calhoun TF, Vinarsky V, Hardin CC.

Abstract:

Link para artigo

Spontaneous and Severe Haematomas in Patients with COVID-19 on Low- Molecular-Weight Heparin for Paroxysmal Atrial Fibrillation

Mazzitelli M, Serapide F, Tassone B, Laganà D, Trecarichi EM, Torti C.

Abstract:

Link para artigo

Immune Thrombocytopenic Purpura in Patients with COVID-19

Revuz S, Vernier N, Saadi L, Campagne J, Poussing S, Maurier F.

Abstract:

Link para artigo

Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19

Seelhammer TG, Rowse P, Yalamuri S.

Abstract:

Link para artigo

[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina]

Vazquez FJ, Korin J, Baldessari EM, Capparelli FJ, Gutierrez P, Pale C, Bocanegra F, Grand B, Penchasky D, Gonzalez Alcántara MM, Prémoli MS, Tabares A, Wainsztein N, Odetto D, Vaccaro C, Martínez Aquino E, Cumpian O, Falabella V, Antuel García S, Saadi J, Siccardi M, Gándara E.

Abstract:

Link para artigo

Heparin induced thrombocytopenia antibodies in COVID-19

Patell R, Khan A, Bogue T, Merrill M, Koshy A, Bindal P, Joyce R, Aird WC, Neuberg D, Bauer KA, Zwicker JI.

Abstract:

Link para artigo

Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions

Kim SY, Jin W, Sood A, Montgomery DW, Grant OC, Fuster MM, Fu L, Dordick JS, Woods RJ, Zhang F, Linhardt RJ.

Abstract:

Link para artigo

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Zhang Y, Cao W, Jiang W, Xiao M, Li Y, Tang N, Liu Z, Yan X, Zhao Y, Li T, Zhu T.

Abstract:

Link para artigo

Aortic thrombus in patients with severe COVID-19: review of three cases

de Carranza M, Salazar DE, Troya J, Alcázar R, Peña C, Aragón E, Domínguez M, Torres J, Muñoz-Rivas N.

Abstract:

Link para artigo

Mortality and the use of Antithrombotic Therapies among Nursing Home Residents with COVID-19

Brouns SH, Brüggemann R, Linkens A, Magdelijns FJ, Joosten H, Heijnen R, Ten Cate-Hoek AJ, Schols J, Ten Cate H, Spaetgens B.

Abstract:

Link para artigo

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

Paar V, Wernly B, Zhou Z, Motloch LJ, Hoppe UC, Egle A, Lichtenauer M.

Abstract:

Link para artigo

A possible benefit from therapeutic anticoagulation in COVID-19: the Dolo hospital experience in Veneto, Italy

Secco E, Pasqualetto MC, Bombardini T, Picano E, Rigo F.

Abstract:

Link para artigo

Anticoagulation clinic drive-up service during COVID-19 pandemic in Qatar

Alhmoud E, Abdelsamad O, Soaly E, Enany RE, Elewa H.

Abstract:

Link para artigo

Successful use of tPA for thrombolysis in COVID related ARDS: a case series

Goyal A, Saigal S, Niwariya Y, Sharma J, Singh P.

Abstract:

Link para artigo

A Case of COVID-19 Infection With Delayed Thromboembolic Complication on Warfarin

Garg A, Goyal S, Patel P.

Abstract:

Link para artigo

Heparin 2.0: A New Approach to the Infection Crisis

Seffer MT, Cottam D, Forni LG, Kielstein JT.

Abstract:

Link para artigo

Lupus anticoagulant is frequent in patients with Covid-19: Response to Reply

Harzallah I, Debliquis A, Drénou B.

Abstract:

Link para artigo

Mechanisms of stroke and the role of anticoagulants in COVID-19

Mishra AK, Sahu KK, Lal A, Sargent J.

Abstract:

Link para artigo

A case of Covid-19 patient with acute limb ischemia and heparin resistance

Baccellieri D, Bilman V, Apruzzi L, Monaco F, D'Angelo A, Loschi D, Melissano G, Chiesa R.

Abstract:

Link para artigo

Management of ST-Elevation Myocardial Infarction in the COVID-19 Era: The Role of Thrombosis and Anticoagulation Strategy

Al-Sadawi M, Mohiuddin A, Hossain N, Shaikh S, Feit A, Ramalanjaona B, Salifu MO, McFarlane SI.

Abstract:

Link para artigo

COVID-19 mortality in patients on anticoagulants and antiplatelet agents

Sivaloganathan H, Ladikou EE, Chevassut T.

Abstract:

Link para artigo

The utility of native MS for understanding the mechanism of action of repurposed therapeutics in COVID-19: heparin as a disruptor of the SARS-CoV-2 interaction with its host cell receptor

Yang Y, Du Y, Kaltashov IA.

Abstract:

Link para artigo

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

Tandon R, Sharp JS, Zhang F, Pomin VH, Ashpole NM, Mitra D, Jin W, Liu H, Sharma P, Linhardt RJ.

Abstract:

Link para artigo

ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19

Bousquet G, Falgarone G, Deutsch D, Derolez S, Lopez-Sublet M, Goudot FX, Amari K, Uzunhan Y, Bouchaud O, Pamoukdjian F.

Abstract:

Link para artigo

Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients

Ghani MU, Kumar M, Ghani U, Sonia F, Abbas SA.

Abstract:

Link para artigo

Correction to: Heparin resistance in COVID‑19 patients in the intensive care unit

White D, MacDonald S, Bull T, Hayman M, de Monteverde-Robb D, Sapsford D, Lavinio A, Varley J, Johnston A, Besser M, Thomas W.

Abstract:

Link para artigo

Current Perspectives of Anticoagulation in Patients with COVID-19

Gavioli EM, Sikorska G, Man A, Rana J, Vider E.

Abstract:

Link para artigo

Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era

Rossi R, Coppi F, Talarico M, Boriani G.

Abstract:

Link para artigo

Curative anticoagulation prevents endothelial lesion in COVID-19 patients

Khider L, Gendron N, Goudot G, Chocron R, Hauw-Berlemont C, Cheng C, Rivet N, Pere H, Roffe A, Clerc S, Lebeaux D, Debuc B, Veyer D, Rance B, Gaussem P, Bertil S, Badoual C, Juvin P, Planquette B, Messas E, Sanchez O, Hulot JS, Diehl JL, Mirault T, Smadja DM.

Abstract:

Link para artigo

COVID-19 anticoagulation recommendations in children

Loi M, Branchford B, Kim J, Self C, Nuss R.

Abstract:

Link para artigo

The Role of Anticoagulation in COVID-19-Induced Hypercoagulability

Rico-Mesa JS, Rosas D, Ahmadian-Tehrani A, White A, Anderson AS, Chilton R.

Abstract:

Link para artigo

Antithrombotic Therapies in COVID-19 Disease: a Systematic Review

Maldonado E, Tao D, Mackey K.

Abstract:

Link para artigo

Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy

Turshudzhyan A.

Abstract:

Link para artigo

Acute cor pulmonale from saddle pulmonary embolism in a patient with previous Covid-19 - should we prolong prophylactic anticoagulation?

Ali S, Pappachan JM, Mathew S.

Abstract:

Link para artigo

Fibrinolysis and COVID-19: a plasmin paradox

Medcalf RL, Keragala CB, Myles PS.

Abstract:

Link para artigo

Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review

Barrett CD, Moore HB, Moore EE, McIntyre RC, Moore PK, Burke J, Hua F, Apgar J, Talmor DS, Sauaia A, Liptzin DR, Veress LA, Yaffe MB.

Abstract:

Link para artigo

Using heparin molecules to manage COVID-2019

Liu J, Li J, Arnold K, Pawlinski R, Key NS.

Abstract:

Link para artigo

Emergence of institutional antithrombotic protocols for coronavirus 2019

Cohoon KP, Mahé G, Tafur AJ, Spyropoulos AC.

Abstract:

Link para artigo

Rethinking COVID-19 'pneumonia' - is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?

Low TT, Cherian R, Lim SL, Chandra B, Tung ML, Kumar SK, Lye P, Chin Xin Yi A, Teo L, Tay EL.

Abstract:

Link para artigo

COVID-19 HASTENS A STRUCTURAL SHIFT IN THE LCD MARKET

Dickson G.

Abstract:

Link para artigo

Should lCU COVID-19 patients empirically receive therapeutic doses of anticoagulant?

Di Perri G.

Abstract:

Link para artigo

Should lCU COVID-19 patients empirically receive therapeutic doses of anticoagulant?

Piazza O.

Abstract:

Link para artigo

The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner

Yamamoto M, Kiso M, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Imai M, Takeda M, Kinoshita N, Ohmagari N, Gohda J, Semba K, Matsuda Z, Kawaguchi Y, Kawaoka Y, Inoue JI.

Abstract:

Link para artigo

Pulmonary Artery Embolism in COVID-19 Despite Thrombosis Prophylaxis

Geerdes-Fenge HF, Reisinger EC, Arndt H.

Abstract:

Link para artigo

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment

Aryal MR, Gosain R, Donato A, Pathak R, Bhatt VR, Katel A, Kouides P.

Abstract:

Link para artigo

COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?

Ferrandis R, Llau JV, Quintana M, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A.

Abstract:

Link para artigo

COVID-19 Experience in Hemodialysis Patients: A Cue for Therapeutic Heparin-Based Strategies?

Pisani A, Rizzo M, Angelucci V, Riccio E.

Abstract:

Link para artigo

Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis

Rivas-Pollmar MI, Álvarez-Román MT, Butta-Coll NV, Martín Salces M, García-Barcenilla S, Jiménez-Yuste V.

Abstract:

Link para artigo

Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance!

Tomasa-Irriguible TM, Martínez-Vega S, Mor-Marco E, Herraiz-Ruiz A, Raguer-Pardo L, Cubells-Larrosa C.

Abstract:

Link para artigo

Heparin as a Therapy for COVID-19: Current Evidence and Future Possibilities

Hippensteel JA, LaRiviere WB, Colbert JF, Langouët-Astrié CJ, Schmidt EP.

Abstract:

Link para artigo

Anticoagulation with Argatroban in patients with acute antithrombin deficiency in severe COVID -19

Arachchillage DJ, Remmington C, Rosenberg A, Xu T, Passariello M, Hall D, Laffan AM, Patel BV.

Abstract:

Link para artigo

Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 (COVID-19) pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society

Kosior DA, Undas A, Kopeć G, Hryniewiecki T, Torbicki A, Mularek-Kubzdela T, Windyga J, Pruszczyk P.

Abstract:

Link para artigo

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases

Poli D, Tosetto A, Palareti G, Barcellona D, Ciampa A, Grandone E, Manotti C, Moia M, Squizzato A, Toschi V, Testa S; On the behalf of Italian Federation of Anticoagulation Clinics (FCSA).

Abstract:

Link para artigo

Thromboprophylaxis in COVID-19: Anti-FXa - The Missing Factor?

Dutt T, Simcox D, Downey C, McLenaghan D, King C, Gautam M, Lane S, Burhan H.

Abstract:

Link para artigo

Pharmacists reinventing their roles to effectively respond to COVID-19: a global report from the international pharmacists for anticoagulation care taskforce (iPACT)

Alves da Costa F, Lee V, Leite SN, Murillo MD, Menge T, Antoniou S.

Abstract:

Link para artigo

Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report

Papamichalis P, Papadogoulas A, Katsiafylloudis P, Skoura AL, Papamichalis M, Neou E, Papadopoulos D, Karagiannis S, Zafeiridis T, Babalis D, Komnos A.

Abstract:

Link para artigo

Is there a rationale for heparin use among severe COVID-19 patients?

Savioli F.

Abstract:

Link para artigo

The association between treatment with heparin and survival in patients with Covid-19

Ayerbe L, Risco C, Ayis S.

Abstract:

Link para artigo

Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study

Russo V, Di Maio M, Attena E, Silverio A, Scudiero F, Celentani D, Lodigiani C, Di Micco P.

Abstract:

Link para artigo

Clinical differentiation of anticoagulant and non-anticoagulant properties of heparin

Thachil J.

Abstract:

Link para artigo

A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19

Kumar P, Mediwake R, Rhead C.

Abstract:

Link para artigo

Heparin-Related Major Bleeding in Covid-19-Positive Patient: Perspective from the Outbreak

Lucatelli P, De Rubeis G, Citone M, Lucarelli NM, Pasqualini V, Sturiale M, Giuliani S, Rosati M, Ceccherini C, Corona M, Mosconi C, Utili A, Argirò R.

Abstract:

Link para artigo

Thromboprophylaxis for medical inpatients with COVID-19

Dalager-Pedersen M, Bodilsen J.

Abstract:

Link para artigo

Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial"

Marietta M, Tripodi A.

Abstract:

Link para artigo

Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial

Cattaneo M, Morici N.

Abstract:

Link para artigo

COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence

Coppola A, Lombardi M, Tassoni MI, Carolla G, Tala M, Morandini R, Paoletti O, Testa S.

Abstract:

Link para artigo

Thrombosis and coagulopathy in COVID-19 patients requiring extracorporeal membrane oxygenation

Yusuff H, Zochios V, Brodie D.

Abstract:

Link para artigo

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum

Barnes GD, Burnett A, Allen A, Blumenstein M, Clark NP, Cuker A, Dager WE, Deitelzweig SB, Ellsworth S, Garcia D, Kaatz S, Minichiello T.

Abstract:

Link para artigo

Covid-19 and thrombosis: what do we know about the risks and treatment?

Wise J.

Abstract:

Link para artigo

Is Biologic Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic Different from Psoriasis Biologic Treatment?

Rosi E, Pimpinelli N, Prignano F.

Abstract:

Link para artigo

Anti-Coagulant and Anti-Platelet Therapy in the COVID-19 Patient: A Best Practices Quality Initiative Across a Large Health System

Watson RA, Johnson DM, Dharia RN, Merli GJ, Doherty JU.

Abstract:

Link para artigo

Heparin - an old drug with multiple potential targets in Covid-19 therapy

Lindahl U, Li JP.

Abstract:

Link para artigo

A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic

Speed V, Patel RK, Byrne R, Roberts LN, Arya R.

Abstract:

Link para artigo

Fibrinolysis Shutdown Correlates to Thromboembolic Events in Severe COVID-19 Infection

Wright FL, Vogler TO, Moore EE, Moore HB, Wohlauer MV, Urban S, Nydam TL, Moore PK, McIntyre RC Jr.

Abstract:

Link para artigo

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

George PM, Wells AU, Jenkins RG.

Abstract:

Link para artigo

Pulmonary fibrosis secondary to COVID-19: a call to arms?

Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD, Sverzellati N, Maher TM.

Abstract:

Link para artigo

Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines.

Porfidia A, Pola R.

Abstract:

Link para artigo

Thrombocytopenia and coagulation disorders due to COVID 19 infection with concomitant cardiovascular diseases requiring anti-platelet and anticoagulant therapy, which strategy?

Buioni D, Nardi P, Ruvolo G.

Abstract:

Link para artigo

Problems related with anticoagulant usage during COVID-19 outbreak

Doganci S, Yildirim AK.

Abstract:

Link para artigo

Safe tracheotomy for patients with COVID-19.

Abstract:

Link para artigo

Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients.

Menezes-Rodrigues FS, Padr√£o Tavares JG, Pires de Oliveira M, Guzella de Carvalho R, Ruggero Errante P, Omar Taha M, Fagundes DJ, Caricati-Neto A.

Abstract:

Link para artigo

Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients.

Abstract:

Link para artigo

Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no?

Roncon L, Zuin M, Zonzin P.

Abstract:

Link para artigo

Reply to Rheumatologists' perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?

Ahmed S, Anirvan P.

Abstract:

Link para artigo

Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19.

Abstract:

Link para artigo

The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.

Canonico ME, Siciliano R, Scudiero F, Sanna GD, Parodi G.

Abstract:

Link para artigo

Response to "Lupus anticoagulant is frequent in patients with Covid-19".

Tang N.

Abstract:

Link para artigo

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.

Roncon L, Zuin M, Rigatelli G.

Abstract:

Link para artigo

Arterial thromboembolic complications in COVID-19 in low risk patients despite prophylaxis.

Griffin DO, Jensen A, Khan M, Chin J, Chin K, Parnell R, Awwad C, Patel D.

Abstract:

Link para artigo

Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.

Price E, MacPhie E, Kay L, Lanyon P, Griffiths B, Holroyd C, Abhishek A, Youngstein T, Bailey K, Clinch J, Shaikh M, Rivett A.

Abstract:

Link para artigo

Global rheumatology in the time of COVID-19.

Abstract:

Link para artigo

Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies.

Porfidia A, Pola R.

Abstract:

Link para artigo

Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients.

Lacour T, Semaan C, Genet T, Ivanes F.

Abstract:

Link para artigo

Anticoagulation in COVID-19.

Atallah B, Mallah SI, AlMahmeed W.

Abstract:

Link para artigo

Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend.

Kirtane AJ, Bangalore S.

Abstract:

Link para artigo

Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19.

Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ.

Abstract:

Link para artigo

Type and dose of heparin in COVID-19.

Thachil J, Tang N, Gando S, Falanga A, Levi M, Clark C, Iba T, Cattaneo M.

Abstract:

Link para artigo

[Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology].

Vivas D, Roldán V, Esteve-Pastor MA, Roldán I, Tello-Montoliu A, Ruiz-Nodar JM, Cosín-Sales J, María Gámez J, Consuegra L, Luis Ferreiro J, Marín F, Arrarte V, Anguita M, Cequier Á, Pérez-Villacastín J.

Abstract:

Link para artigo

Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action.

Kollias A, Kyriakoulis KG, Dimakakos E, Poulakou G, Stergiou GS, Syrigos K.

Abstract:

Link para artigo

Potential of Heparin and Nafamostat Combination Therapy for COVID-19.

Asakura H, Ogawa H.

Abstract:

Link para artigo

Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'.

Tang N.

Abstract:

Link para artigo

Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Coto-Hern√°ndez R, F√°bregas Ruano MT.

Abstract:

Link para artigo

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients.

Testa S, Paoletti O, Giorgi-Pierfranceschi M, Pan A.

Abstract:

Link para artigo

COVID-19 and Kawasaki Disease: Novel Virus and Novel Case.

Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Bradley Segal J, Nguyen EL, Barsh GR, Maskatia S, Mathew R.

Abstract:

Link para artigo

The versatile heparin in COVID-19.

Thachil J.

Abstract:

Link para artigo

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z.

Abstract:

Link para artigo

COVID-19 HASTENS A STRUCTURAL SHIFT IN THE LCD MARKET

Dickson G.

Abstract:

Link para artigo

[Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology].

Vivas D, Roldán V, Esteve-Pastor MA, Roldán I, Tello-Montoliu A, Ruiz-Nodar JM, Cosín-Sales J, María Gámez J, Consuegra L, Luis Ferreiro J, Marín F, Arrarte V, Anguita M, Cequier Á, Pérez-Villacastín J.

Abstract:

Link para artigo